Embryo phenotype |
0.023 |
mcm4, npat, thoc1, bap1, dnmt1, yy1, hdac1 |
Increased embryonic tissue cell apoptosis |
0.028 |
thoc1, dnmt1 |
Mortality/aging |
Prenatal lethality |
0.012 |
mcm3, mcm4, thoc1, bap1, dnmt1, yy1, sin3a, hdac1 |
Embryonic lethality, complete penetrance |
0.007 |
mcm4, dnmt1, yy1, hdac1 |
Embryonic lethality between implantation andsomite formation, complete penetrance |
0.036 |
mcm4, sin3a |
Neoplasm |
Increased hemolymphoid system tumor incidence |
0.007 |
mcm4, esr2, h2afx |
Increased T cell derived lymphoma incidence |
0.006 |
mcm4, h2afx |
Cellular phenotype |
Abnormal cell proliferation |
0.022 |
mcm3, mcm4, dnmt1, esr2, h2afx, hdac1 |
Decreased cell proliferation |
0.012 |
mcm3, mcm4, dnmt1, h2afx, hdac1 |
Chromosomal instability |
0.018 |
mcm4, h2afx |
Nervous system phenotype |
Abnormal dopamine level |
0.014 |
esr2, pnkd |